biotech · Relapsed or Refractory B-cell Malignancies · Solid Tumor · RXRX
RECURSION PHARMACEUTICALS
RECURSION PHARMACEUTICALS, INC.
RECURSION PHARMACEUTICALS is a biotech organization headquartered in Staten Island, USA. It trades on NYSE under ticker RXRX. Primary therapeutic focus areas include Relapsed or Refractory B-cell Malignancies, Solid Tumo
Staten Island, USA HQ
11 Employees
Public company Type
RXRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Staten Island, USA
- Employees
- 11
- Programs
- 9
- Drugs
- 2
- Patents
- 4
REC-994
Phase 2 · small molecule · Cerebral Cavernous Malformation
REC-994 for Cerebral Cavernous Malformation is a Phase 2 program (small_molecule) at RECURSION PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Internal code REC-994-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- RECURSION PHARMACEUTICALS, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Cerebral Cavernous Malformation
- Status
- completed
- Trials
- 1